Equities

Syra Health Corp

SYRA:NAQ

Syra Health Corp

Actions
Health CareHealth Care Providers
  • Price (USD)1.39
  • Today's Change0.02 / 1.46%
  • Shares traded69.61k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Syra Health Corp. is a healthcare services company. The Company provides comprehensive end-to-end solutions in behavioral and mental health, population health, digital health, health education and healthcare workforce. The Company’s health education service line offers services, including medical communications, patient education, and healthcare training. Its population health management services include analytics as a service, epidemiology and health equity analytics solutions. The Company’s digital health solutions include digital transformation, cloud and security, artificial intelligence, patient engagement, and health applications. Its Syrenity is a comprehensive mental health application that provides preventative care and interventions for behavioral and mental health. It provides medical education solutions to pharmaceutical and medical device manufacturers, biotechnology companies, payers, large employers, academic institutions, and government agencies.

  • Revenue in USD (TTM)6.08m
  • Net income in USD-3.60m
  • Incorporated2022
  • Employees78.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Greenbrook TMS Inc72.49m-52.54m5.13m629.00------0.0707-1.24-1.241.71-2.450.9471--6.22---69.41-68.51-113.55-106.4525.9238.65-73.29-76.82---2.40136.38--10.4228.2644.21---54.79--
US NeuroSurgical Holdings Inc0.00-1.02m5.53m2.00--11.43-----0.1156-0.11560.000.03590.00----0.00-47.81-14.62-130.00-19.89-------36.77---20.960.00------38.97------
Interpace Biosciences Inc40.66m1.25m6.33m108.005.16--3.200.15580.28020.20229.27-3.342.9014.328.37376,481.508.95-38.19---69.7359.0249.443.08-41.010.43553.11----26.3112.93118.96--0.9184--
Biocorrx Inc52.35k-3.99m7.02m5.00------134.05-0.464-0.4640.0061-1.210.102--0.9969---778.76-291.68----44.6467.13-7,635.86-3,208.40---3.49-----58.31-25.0413.79------
Selectis Health Inc36.67m-9.06m7.67m574.00------0.2091-2.96-2.9611.99-1.310.8309--15.6863,884.65-20.46-3.03-30.08-3.58-----24.63-4.84---3.361.12---9.4058.97-64.93---47.72--
Syra Health Corp6.08m-3.60m8.93m78.00--2.66--1.47-0.5946-0.59461.050.52241.77--10.1977,937.56-105.01---154.43--23.75---59.21-----83.830.0279---1.83---38.72------
Mangoceuticals Inc844.87k-9.02m9.77m--------11.56-0.492-0.4920.0455-0.04060.3826-------408.41---596.95--61.75---1,067.52--0.0622------8,082.22---361.07------
Pacific Health Care Organization Inc5.72m834.22k10.05m30.0012.060.913411.531.760.06510.06510.44590.85950.4725--6.09190,503.306.907.297.427.8179.4282.7514.6013.28----0.00---2.00-3.7055.80-10.80-15.93--
Caremax Inc810.36m-644.67m11.14m1.45k--0.5461--0.0138-172.31-172.31216.425.360.9467--6.07558,871.80-75.32---114.67---0.1988---79.55-----1.840.9506--19.01---1,707.99------
Medical Care Technologies Inc.0.00-1.07m11.23m0.00---------553,570.10-553,570.100.00-389.230.00-------154.94-----------------1.46---------40.06------
Xcelerate Inc3.96m-296.19k12.11m1.00--8.70--3.06-0.0014-0.00140.01890.00321.516.133.90---11.334.24-49.19--71.7174.10-7.481.930.4797-0.82180.7237--6.6310.4317.00--174.06--
Aesthetic Medical Intl Hldg Grp Ltd(ADR)94.26m-5.17m12.42m1.29k--1.843.460.1318-0.1178-0.11782.210.14131.2316.6085.1473,297.39-7.21-23.36-44.53-48.5847.1855.32-5.85-23.720.2333-3.700.8791--1.86-2.1650.91--3.70--
Univec Inc-100.00bn-100.00bn12.87m3.00---------------0.0113-----------50.96------17.47---198.310.0051-------74.07-64.8336.83------
Clearday Inc7.54m-21.54m13.35m225.00------1.77-0.9722-0.99380.3147-1.700.3432--201.6333,524.13-77.04-71.37---342.36-----224.52-205.25---0.9413-----3.0594.7325.38---28.32--
Data as of May 31 2024. Currency figures normalised to Syra Health Corp's reporting currency: US Dollar USD

Institutional shareholders

1.58%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202434.25k0.60%
Geode Capital Management LLCas of 31 Mar 202425.57k0.45%
Two Sigma Securities LLCas of 31 Mar 202410.55k0.18%
D. L. Carlson Investment Group, Inc.as of 31 Mar 202410.00k0.17%
Tower Research Capital LLCas of 31 Mar 20246.01k0.11%
UBS Securities LLCas of 31 Mar 20243.46k0.06%
NewEdge Advisors LLCas of 31 Mar 20241.00k0.02%
Wells Fargo Bank, NA (Private Banking)as of 31 Mar 202416.000.00%
JPMorgan Securities LLC (Investment Management)as of 31 Mar 20244.000.00%
Torno Capital LLCas of 31 Mar 20240.000.00%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.